Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria.

Proceedings of the National Academy of Sciences of the United States of America
Han-Xiang DengTeepu Siddique

Abstract

Twenty percent of the familial form of amyotrophic lateral sclerosis (ALS) is caused by mutations in the Cu, Zn-superoxide dismutase gene (SOD1) through the gain of a toxic function. The nature of this toxic function of mutant SOD1 has remained largely unknown. Here we show that WT SOD1 not only hastens onset of the ALS phenotype but can also convert an unaffected phenotype to an ALS phenotype in mutant SOD1 transgenic mouse models. Further analyses of the single- and double-transgenic mice revealed that conversion of mutant SOD1 from a soluble form to an aggregated and detergent-insoluble form was associated with development of the ALS phenotype in transgenic mice. Conversion of WT SOD1 from a soluble form to an aggregated and insoluble form also correlates with exacerbation of the disease or conversion to a disease phenotype in double-transgenic mice. This conversion, observed in the mitochondrial fraction of the spinal cord, involved formation of insoluble SOD1 dimers and multimers that are crosslinked through intermolecular disulfide bonds via oxidation of cysteine residues in SOD1. Our data thus show a molecular mechanism by which SOD1, an important protein in cellular defense against free radicals, is converted to aggrega...Continue Reading

Associated Clinical Trials

Jan 13, 2009·Teepu Siddique

References

Dec 1, 1988·The Journal of Cell Biology·L Y ChangJ D Crapo
Dec 2, 2000·Nature Medicine·D W Cleveland, J Liu
May 12, 2001·Mechanisms of Ageing and Development·D A Butterfield, J Kanski
Apr 30, 2002·Free Radical Biology & Medicine·M Flint Beal
Jun 18, 2002·Science·J Paul TaylorKenneth H Fischbeck
Nov 30, 2002·The Journal of Biological Chemistry·Ashutosh Tiwari, Lawrence J Hayward
May 16, 2003·The Journal of Biological Chemistry·Lori Sturtz FieldValeria Cizewski Culotta
May 22, 2003·Free Radical Biology & Medicine·Stefan I Liochev, Irwin Fridovich
Oct 10, 2003·Brain : a Journal of Neurology·P Andreas JonssonStefan L Marklund
Jun 25, 2004·The EMBO Journal·Yoshiaki FurukawaThomas V O'Halloran
Jun 26, 2004·Annual Review of Neuroscience·Lucie I BruijnDon W Cleveland
Mar 11, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Chetan VijayvergiyaGiovanni Manfredi
Apr 29, 2005·Brain Research. Molecular Brain Research·Yasuhiro WatanabeKenji Nakashima
Dec 7, 2005·Brain : a Journal of Neurology·P Andreas JonssonStefan L Marklund

❮ Previous
Next ❯

Citations

Jun 28, 2011·Mammalian Genome : Official Journal of the International Mammalian Genome Society·Peter I JoyceAbraham Acevedo-Arozena
Jun 17, 2010·Journal of Neural Transmission·Ana G BarbeitoSéverine Boillée
Oct 12, 2010·Journal of Neural Transmission·Brandon K HarveyMikko Airavaara
Nov 15, 2011·Journal of Bioenergetics and Biomembranes·Maria Teresa Carrì, Mauro Cozzolino
Jun 21, 2008·Neuromolecular Medicine·P Hemachandra Reddy
Aug 27, 2013·Trends in Molecular Medicine·Alex MotzikEhud Razin
Jun 29, 2007·Expert Reviews in Molecular Medicine·Jean-Christophe Rochet
May 9, 2007·Nature Medicine·Rishi RakhitAvijit Chakrabartty
Aug 23, 2006·Nature Reviews. Neuroscience·Piera Pasinelli, Robert H Brown
Nov 22, 2008·Proceedings of the National Academy of Sciences of the United States of America·Madhuri ChattopadhyayJoan Selverstone Valentine
Apr 17, 2009·Proceedings of the National Academy of Sciences of the United States of America·Lucia BanciMiguela Vieru
Mar 3, 2009·Proceedings of the National Academy of Sciences of the United States of America·Christian S LobsigerDon W Cleveland
May 30, 2009·Proceedings of the National Academy of Sciences of the United States of America·Caryn NavarroRuth Lehmann
Oct 16, 2009·Proceedings of the National Academy of Sciences of the United States of America·Kaare TeilumMikael Akke
Nov 26, 2010·Proceedings of the National Academy of Sciences of the United States of America·Jared R AuclairJeffrey N Agar
Sep 21, 2011·Proceedings of the National Academy of Sciences of the United States of America·Leslie I GradNeil R Cashman
Aug 5, 2009·The Journal of Biological Chemistry·Ashutosh TiwariLawrence J Hayward
Jul 29, 2010·The Journal of Biological Chemistry·Mary Anne SahawnehAlvaro G Estévez
Aug 2, 2006·The Journal of Biological Chemistry·Mark C CarrollValeria Cizewski Culotta
Aug 22, 2008·The Journal of Biological Chemistry·Hibiki KawamataGiovanni Manfredi
Nov 3, 2011·Journal of Toxicology and Environmental Health. Part a·Will C GuestNeil R Cashman
Mar 29, 2008·Antioxidants & Redox Signaling·Mauro CozzolinoMaria Teresa Carrì
Mar 11, 2009·Antioxidants & Redox Signaling·Madhuri Chattopadhyay, Joan Selverstone Valentine
Apr 7, 2009·Antioxidants & Redox Signaling·Mauro CozzolinoMaria Teresa Carrì
Apr 7, 2009·Antioxidants & Redox Signaling·Jordi Magrané, Giovanni Manfredi
Jun 22, 2010·Antioxidants & Redox Signaling·Melissa NassifClaudio Hetz
Apr 7, 2010·Antioxidants & Redox Signaling·Johannes M Herrmann, Jan Riemer
Apr 7, 2010·Antioxidants & Redox Signaling·Hibiki Kawamata, Giovanni Manfredi
Jul 24, 2010·Human Gene Therapy·Takayuki KuboderaTakanori Yokota
May 21, 2013·Brain : a Journal of Neurology·Rachele A SacconPietro Fratta
Aug 16, 2008·Human Molecular Genetics·Hibiki Kawamata, Giovanni Manfredi
Feb 24, 2009·Human Molecular Genetics·Lijun WangRaymond P Roos

❮ Previous
Next ❯

Related Concepts

Related Feeds

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating genetic alterations in this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

© 2022 Meta ULC. All rights reserved